WO2002016439A8 - Nouveaux acides nucleiques et polypeptides - Google Patents
Nouveaux acides nucleiques et polypeptidesInfo
- Publication number
- WO2002016439A8 WO2002016439A8 PCT/US2001/004941 US0104941W WO0216439A8 WO 2002016439 A8 WO2002016439 A8 WO 2002016439A8 US 0104941 W US0104941 W US 0104941W WO 0216439 A8 WO0216439 A8 WO 0216439A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polypeptides
- nucleic acids
- novel nucleic
- novel
- acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6432—Coagulation factor Xa (3.4.21.6)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21006—Coagulation factor Xa (3.4.21.6)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001277840A AU2001277840A1 (en) | 2000-03-07 | 2001-03-05 | Novel nucleic acids and polypeptides |
US10/128,558 US20040219521A1 (en) | 2000-01-21 | 2002-04-22 | Novel nucleic acids and polypeptides |
US10/243,552 US20030224379A1 (en) | 2000-01-21 | 2002-09-12 | Novel nucleic acids and polypeptides |
US10/302,689 US20080050393A1 (en) | 1998-12-03 | 2002-11-22 | Novel nucleic acids and polypeptides |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51970500A | 2000-03-07 | 2000-03-07 | |
US09/519,705 | 2000-03-07 | ||
US57445400A | 2000-05-19 | 2000-05-19 | |
US09/574,454 | 2000-05-19 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/008631 Continuation-In-Part WO2001075067A2 (fr) | 1998-12-03 | 2001-03-30 | Nouveaux acides nucleiques et polypeptides |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/004927 Continuation-In-Part WO2001064835A2 (fr) | 1998-12-03 | 2001-02-26 | Nouveaux acides nucleiques et polypeptides |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002016439A2 WO2002016439A2 (fr) | 2002-02-28 |
WO2002016439A8 true WO2002016439A8 (fr) | 2002-06-27 |
Family
ID=27059936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/004941 WO2002016439A2 (fr) | 1998-12-03 | 2001-03-05 | Nouveaux acides nucleiques et polypeptides |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001277840A1 (fr) |
WO (1) | WO2002016439A2 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8958881B2 (en) | 2005-08-19 | 2015-02-17 | Brainsgate Ltd. | Neuroprotective electrical stimulation |
US9233245B2 (en) | 2004-02-20 | 2016-01-12 | Brainsgate Ltd. | SPG stimulation |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2368904A1 (fr) * | 2001-03-14 | 2011-09-28 | Genencor International, Inc. | Croissance régulable des champignons filamenteux |
EP1590437A4 (fr) | 2003-01-24 | 2008-06-18 | Agensys Inc | Acides nucleiques et proteines correspondantes dites 254p1d6b utiles pour la detection et le traitement du cancer |
US7198791B2 (en) * | 2003-03-03 | 2007-04-03 | Pluschke, Gerd Et Al. | Compositions and methods for the generation of protective immune responses against malaria |
EP1642135A1 (fr) * | 2003-06-06 | 2006-04-05 | AstraZeneca AB | Methode de diagnostic de maladies inflammatoires intestinales |
US8010189B2 (en) | 2004-02-20 | 2011-08-30 | Brainsgate Ltd. | SPG stimulation for treating complications of subarachnoid hemorrhage |
PL1858920T3 (pl) | 2005-02-18 | 2016-12-30 | Białka i kwasy nukleinowe z Escherichia coli związane z zapaleniem opon mózgowych/sepsą | |
CA2634934A1 (fr) * | 2005-12-23 | 2007-07-05 | The Burnham Institute For Medical Research | Peptide de ciblage de cellule d'endometriose et ses utilisations |
US7897568B2 (en) * | 2006-03-03 | 2011-03-01 | Vinay K. Singh | Compositions for treatment of cancer |
US9675796B2 (en) | 2013-11-10 | 2017-06-13 | Brainsgate Ltd. | Implant and delivery system for neural stimulator |
EP3093043B1 (fr) | 2015-05-13 | 2018-11-14 | Brainsgate Ltd. | Implant et système de distribution pour stimulateur neural |
WO2024089627A1 (fr) * | 2022-10-26 | 2024-05-02 | Berking Biotechnology Spa | Anticorps à domaine unique -sdab/vhh dirigé contre la nucléoprotéine du virus sars-cov-2 |
-
2001
- 2001-03-05 WO PCT/US2001/004941 patent/WO2002016439A2/fr active Application Filing
- 2001-03-05 AU AU2001277840A patent/AU2001277840A1/en not_active Abandoned
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9233245B2 (en) | 2004-02-20 | 2016-01-12 | Brainsgate Ltd. | SPG stimulation |
US8958881B2 (en) | 2005-08-19 | 2015-02-17 | Brainsgate Ltd. | Neuroprotective electrical stimulation |
Also Published As
Publication number | Publication date |
---|---|
AU2001277840A1 (en) | 2002-03-04 |
WO2002016439A2 (fr) | 2002-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001249251A1 (en) | Novel nucleic acids and polypeptides | |
AU2001243142A1 (en) | Novel nucleic acids and polypeptides | |
AU2001234944A1 (en) | Novel nucleic acids and polypeptides | |
AU2001290548A1 (en) | Novel nucleic acids and polypeptides | |
AU2001245280A1 (en) | Novel nucleic acids and polypeptides | |
AU2001233041A1 (en) | Novel nucleic acids and polypeptides | |
AU2001238347A1 (en) | Novel nucleic acids and polypeptides | |
AU2001296235A1 (en) | Novel nucleic acids and polypeptides | |
AU2001263006A1 (en) | Novel nucleic acids and polypeptides | |
AU2001233017A1 (en) | Novel nucleic acids and polypeptides | |
AU2002246502A1 (en) | Nucleic acids and polypeptides | |
AU2002366951A1 (en) | Novel nucleic acids and polypeptides | |
AU2002326877A1 (en) | Novel nucleic acids and polypeptides | |
AU2002314709A1 (en) | Novel nucleic acids and polypeptides | |
AU2002343417A1 (en) | Novel nucleic acids and polypeptides | |
AU2001241511A1 (en) | Novel nucleic acids and polypeptides | |
AU2001292561A1 (en) | Nucleic acids and polypeptides | |
AU2001250872A1 (en) | Novel nucleic acids and polypeptides | |
AU2001277840A1 (en) | Novel nucleic acids and polypeptides | |
EP1341803A4 (fr) | Nouveaux acides nucleiques et polypeptides | |
AU3511100A (en) | Novel nucleic acids and polypeptides | |
AU2002250419A1 (en) | Novel nucleic acids and polypeptides | |
AU2001263005A1 (en) | Novel nucleic acids and polypeptides | |
AU2001252926A1 (en) | Novel nucleic acids and polypeptides | |
EP1268762A4 (fr) | Nouveaux acides nucleiques et polypeptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10128558 Country of ref document: US |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
D17 | Declaration under article 17(2)a | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10243552 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10245014 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |